Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Peapack Gladstone Financial Aktie 836130 / US7046991078

06.11.2025 16:20:43

EQS-News: Peapack Private Investment Banking Advises ACA Computers on Strategic Sale to Network Coverage

EQS-News: Peapack-Gladstone Financial Corporation / Key word(s): Financial
Peapack Private Investment Banking Advises ACA Computers on Strategic Sale to Network Coverage

06.11.2025 / 16:20 CET/CEST
The issuer is solely responsible for the content of this announcement.


BEDMINSTER, NJ - November 6, 2025 (NEWMEDIAWIRE) - Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC), the holding company for Peapack Private Bank & Trust and its investment banking subsidiary, Peapack Private Investment Banking, is pleased to announce its advisory role in the sale of ACA Computers, LLC (“ACA”) to Network Coverage. Peapack Private advised ACA’s selling shareholders, JP Pladek and Paul Schmalz, throughout the transaction. Financial terms were not disclosed.

690cb716da846f6040d59d2c_1

ACA, a trusted provider of managed IT services for mid-sized businesses, has built a 21-year legacy of excellence in system design and deployment, help desk support, remote IT services, data backup, and cloud computing. The company delivers comprehensive commercial IT solutions, including 24/7 monitoring, cybersecurity, strategic IT planning, and scalable, flat-rate services tailored to diverse industries.

The acquisition by Network Coverage, a full-service Managed Service Provider backed by Tenex Capital Management, marks a new chapter for ACA. This strategic partnership expands ACA’s capabilities and strengthens its ability to deliver exceptional IT support to a geographically diverse client base.

JP Pladek, ACA’s Founder and President, commented, “I am thrilled to join forces with Network Coverage to elevate the service our clients depend on. Their leadership team shares our commitment to innovation and white-glove service. I am also deeply grateful to Peapack Private for their industry insight and guidance, which were instrumental in achieving a seamless and successful transaction.”

Peapack Private Investment Banking provides strategic advisory and direct lending solutions to middle-market companies across all industries. The team is known for its collaborative approach and deep expertise in navigating complex financial transactions. This deal highlights another successful engagement in the business services sector.

"Helping our clients realize the value of what they have built is incredibly rewarding. Combined with our wealth management capabilities, we offer a truly differentiated experience," said Matthew Luczyk, Senior Vice President, Head of Corporate Advisory.

Key contributors to the transaction included:

  • Matthew Luczyk, SVP, Head of Corporate Advisory
  • John Bolebruch, Senior Advisor (In Memoriam)
  • David Markovich, Analyst, Corporate Advisory
  • Robert Vogel, Senior Managing Director, Wealth Management
  • Brett Flynn, Managing Director, Wealth Management

About the Company

Peapack-Gladstone Financial Corporation is a New Jersey bank holding company with total assets of $7.4 billion and assets under management and/or administration of $12.9 billion as of September 30, 2025. Founded in 1921, Peapack Private Bank & Trust is a commercial bank that offers a client-centric approach to banking, providing high-quality products along with customized and innovative wealth management, investment banking, commercial and personal banking solutions. The Bank's wealth management division offers comprehensive financial, tax, fiduciary and investment advice and solutions to individuals, families, privately held businesses, family offices, and not-for-profit organizations, which help them establish, maintain, and expand their legacy. Peapack Private Bank & Trust offers an unparalleled commitment to client service. Visit www.peapackprivate.com for more information.

Contact: Denise Pace-Sanders, Peapack Private Bank & Trust, SVP Managing Principal, Brand and Marketing Director, 500 Hills Drive, Suite 300, Bedminster, NJ  07921, dpace@peapackprivate.com, (908) 470-3322

View the original release on www.newmediawire.com


News Source: Peapack-Gladstone Financial Corporation


06.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Peapack-Gladstone Financial Corporation
United States
ISIN: US7046991078
EQS News ID: 2225414

 
End of News EQS News Service

2225414  06.11.2025 CET/CEST

Analysen zu Peapack Gladstone Financial Corp

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’193.40 19.16 SJ6B5U
Short 13’444.90 13.69 U2TBSU
Short 13’930.53 8.90 SY9BNU
SMI-Kurs: 12’702.08 11.11.2025 17:30:12
Long 12’163.68 19.77 SO2B2U
Long 11’889.18 13.84 SZDBEU
Long 11’379.10 8.90 SPMBUU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com